v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05449379 |
Full text link
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
mariusz.ciolkiewicz@umb.edu.pl |
Registration date
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
2022-07-08 |
Recruitment status
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Recruiting |
Study design
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Long covid |
Inclusion criteria
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
inclusion criteria: covid 19 infection confirmed with a positive pcr (polymerase chain reaction) sars-cov-2 (severe scute respiratory syndrome coronavirus type 2) test less than 12 moths prior to intervention more than 14 days from the day of obtaining a positive pcr test result for sars-cov-2 or discharge from hospital. mmrc (modified medical research council) score ≥1 age >18 years informed consent signed by patient to conduct the study |
Exclusion criteria
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
severe pulmonary disease (e.g. copd) the functional state that makes it impossible to carry out the pre-examination and improvement program severe chest pain worsening dyspnea hemoptysis worsening dry cough syncope worsening oedema of extremities myocarditis (less than 6 months from acute phase) |
Number of arms
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Medical University of Bialystok |
Inclusion age min
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Poland |
Type of patients
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
Severity scale
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
60 |
primary outcome
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
Evaluation of quality of life;Force of respiratory muscles;Physical endurance improvement assessment of 6 MWT distance and outcome of treadmill stress test. |
Notes
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : July 12, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : July 13, 2022, 2 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "nan", "treatment_id": 1692, "treatment_name": "Physical exercises+respiratory exercises+respiratory muscle training", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1109, "treatment_name": "Respiratory exercises", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}] |